title: QT interval prolongation in a patient with LQT2 on levetiracetam.
authors.affiliation: Department of Neurology, University of Chicago, United States. Electronic address: naoumpissa@gmail.com.
authors.forename: Naoum P
authors.initials: NP
authors.lastname: Issa
authors.affiliation: Division of Cardiac Electrophysiology, NorthShore University HealthSystem and Pritzker School of Medicine, University of Chicago, United States.
authors.forename: Westby G
authors.initials: WG
authors.lastname: Fisher
authors.affiliation: Department of Neurology, NorthShore University HealthSystem and Pritzker School of Medicine, University of Chicago, United States. Electronic address: JNarayanan@northshore.org.
authors.forename: Jaishree T
authors.initials: JT
authors.lastname: Narayanan
mesh_terms: D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D000072237:ERG1 Potassium Channel; D004562:Electrocardiography; D004827:Epilepsy / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D051638:Ether-A-Go-Go Potassium Channels / Q000235:genetics; D005260:Female; D005500:Follow-Up Studies; D006321:Heart / Q000187:drug effects / Q000503:physiopathology; D006801:Humans; D000077287:Levetiracetam; D008133:Long QT Syndrome / Q000139:chemically induced* / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D010889:Piracetam / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D017354:Point Mutation; D055815:Young Adult
chemical_list: D000927:Anticonvulsants; D000072237:ERG1 Potassium Channel; D051638:Ether-A-Go-Go Potassium Channels; C000606913:KCNH2 protein, human; D000077287:Levetiracetam; D010889:Piracetam
keywords: KCNH2; LQT2; Levetiracetam; Long QT syndrome; Torsades de pointes